Boston, Massachusetts, United States Partners Innovation Fund is the famous VC, which was founded in 2007. The venture was found in North America in United States. The main department of described VC is located in the Boston.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Syntimmune, lifeIMAGE, Daktari Diagnostics. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Therapeutics, Health Diagnostics.
Speaking about the real fund results, this VC is 10 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Partners Innovation Fund performs on 1 percentage points less the average number of lead investments. The fund is constantly included in 2-6 investment rounds annually. The higher amount of exits for fund were in 2018. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Besides them, we counted 9 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Partners Innovation Fund, startups are often financed by Atlas Venture, Baxalta Ventures, Apple Tree Partners. The meaningful sponsors for the fund in investment in the same round are Atlas Venture, SR One, Baxalta Ventures. In the next rounds fund is usually obtained by Atlas Venture, SR One, Omega Funds.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AirAngels | - |
| Alante Capital | New York, New York, United States |
| Anthill Studio | Andhra Pradesh, Hyderabad, India |
| Atinum Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
| Bailibowen | Beijing, Beijing, China |
| Cattles Invoice Finance | Abingdon, Oxfordshire, United Kingdom |
| Crevisse | Seoul, Seoul-t'ukpyolsi, South Korea |
| Galaxy Holding Group | China, Guangdong, Shenzhen |
| GITS Foods | India, Maharashtra, Mumbai |
| HuaKong Equity Investment | - |
| Juren Capital | China, Hangzhou, Zhejiang |
| LongueVue Capital | Louisiana, Metairie, United States |
| MEDIASEEK | Japan, Shimane, Shimane Prefecture |
| Ministerio de Economia y Competitividad | Community of Madrid, Madrid, Spain |
| Morningside Ventures | - |
| Qiandao Fund | Beijing, Beijing, China |
| Summerfield Capital Management | New York, New York, United States |
| Tongren Boda | China, Jiangsu, Nanjing |
| Working Opportunity Fund | British Columbia, Canada, Vancouver |
| Yosemite | - |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ROME Therapeutics | $50M | 27 Apr 2020 | Cambridge, Massachusetts, United States | ||
SwanBio Therapeutics | $52M | 23 Apr 2020 | Lower Merion Township, Pennsylvania, United States | ||
Affinia Therapeutics | $60M | 31 Mar 2020 | Massachusetts, United States | ||
Keros Therapeutics | $56M | 04 Mar 2020 | Massachusetts, United States | ||
Akouos | $105M | 03 Mar 2020 | Boston, Massachusetts, United States | ||
Triplet Therapeutics | $49M | 17 Dec 2019 | Cambridge, Massachusetts, United States | ||
ZielBio | $25M | 26 Sep 2019 | Virginia, United States | ||
Alizé Pharma | $79M | 31 Jul 2019 | France, Auvergne-Rhône-Alpes, France | ||
Nocion Therapeutics | $27M | 18 Apr 2019 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ROME Therapeutics | $50M | 27 Apr 2020 | Cambridge, Massachusetts, United States | ||
SwanBio Therapeutics | $52M | 23 Apr 2020 | Lower Merion Township, Pennsylvania, United States | ||
Affinia Therapeutics | $60M | 31 Mar 2020 | Massachusetts, United States | ||
Keros Therapeutics | $56M | 04 Mar 2020 | Massachusetts, United States | ||
Akouos | $105M | 03 Mar 2020 | Boston, Massachusetts, United States | ||
Triplet Therapeutics | $49M | 17 Dec 2019 | Cambridge, Massachusetts, United States | ||
ZielBio | $25M | 26 Sep 2019 | Virginia, United States | ||
Alizé Pharma | $79M | 31 Jul 2019 | France, Auvergne-Rhône-Alpes, France | ||
Nocion Therapeutics | $27M | 18 Apr 2019 | Cambridge, Massachusetts, United States |
